2022 · FINDING
CITEDSURMOUNT-1
22.5% weight loss at highest dose
⚕ EDUCATIONAL CONTENT · NOT MEDICAL ADVICE · CONSULT A QUALIFIED PHYSICIAN BEFORE ANY USE
WEIGHT LOSSFDA APPROVED★ TOP SEARCHED
Tirzepatide.
The Dual Agonist That Beats Ozempic
AKA · Mounjaro · Zepbound
WEIGHT LOSSSUBCUTANEOUS
Tirzepatide outperforms semaglutide in head-to-head trials. As a dual GLP-1/GIP agonist, people are losing 20-25% body weight.
~5 days
Half-life
5
Citations
1
Routes
1
Categories
Refrigerate
Storage
95
Popularity
AT A GLANCE.
§ 01 · TL;DRTHE QUICK READ.
Tirzepatide outperforms semaglutide in head-to-head trials. As a dual GLP-1/GIP agonist, people are losing 20-25% body weight.
Activates TWO hunger receptors (GLP-1 and GIP) for a more powerful appetite-suppressing effect.
WHAT IT MIGHT HELP WITH.
1
20-25% body weight loss (best in class)
2
Superior to semaglutide in trials
3
Significant blood sugar improvements
4
Better tolerated by some
5
Improved blood pressure and lipids
HOW IT WORKS.
§ 02 · MECHANISMActivates TWO hunger receptors (GLP-1 and GIP) for a more powerful appetite-suppressing effect.
Dual GIP/GLP-1 receptor agonist providing synergistic effects on appetite, glucose metabolism, and energy expenditure.
WHO IT'S FOR
- ✓Those wanting maximum weight loss
- ✓Semaglutide plateau
- ✓Type 2 diabetics
- ✓BMI ≥30 or ≥27 with comorbidities
WHO SHOULD AVOID
- ✕Medullary thyroid cancer history
- ✕Pancreatitis history
- ✕Pregnant/breastfeeding
THE RESEARCH.
§ 03 · 5 STUDIES2021 · FINDING
CITEDSURPASS-2
Superior A1C reduction vs semaglutide
2024 · FINDING
CITEDSURMOUNT-OSA Trial
Up to 63% reduction in sleep apnea severity (AHI) in patients with obesity
2024 · FINDING
CITEDSURPASS-CVOT
Cardiovascular outcomes trial showing emerging benefit data for heart protection
2024 · FINDING
CITEDSURMOUNT-4 Maintenance
Confirms treatment must continue to maintain weight loss; regain observed after discontinuation
DOSING PROTOCOL.
§ 04 · DOSINGTYPICAL RANGE
Research reported dose
Start 2.5mg weekly, titrate to 15mg over several months
FREQUENCY
Most-cited schedule
Once weekly
ROUTES
Delivery methods
SUBCUTANEOUS
HALF-LIFE
Steady state drives frequency
~5 days
STORAGE
Protect from light, refrigerate
Refrigerate at 36-46°F
⚠ NOTE
These are reported protocols from research literature and practitioner accounts, not prescriptions. No FDA-approved human dose exists for research compounds. Anyone using Tirzepatide should work with a qualified physician and source from a supplier providing third-party COAs.
FORMS AVAILABLE
- · Subcutaneous injection only
⚠ RESEARCH INFORMATION ONLY · NOT MEDICAL ADVICE
SIDE EFFECTS & RISKS.
§ 06 · SAFETY·
Nausea
Common (30%) · mild
·
Diarrhea
Common (20%) · mild
·
Vomiting
Common (15%) · mild
·
Decreased appetite
Common · mild
WHERE TO SOURCE
§ 07 · SUPPLIERPEAK LAB
PEPTIDES
PEPTIDES
SUPPLIER OF RECORD · 12 BATCHES PASSED
We tried nine suppliers across 2025 and kept picking PEAK LAB for Tirzepatide: 99.4% HPLC purity, COA on every batch, cold chain intact. Shop through our link and we earn a small commission — affiliate relationship is disclosed.
COMMON QUESTIONS.
§ 08 · FAQHow does tirzepatide compare to semaglutide in research?
Head-to-head SURPASS trials demonstrated tirzepatide produced greater weight loss and A1C reduction compared to semaglutide 1mg. The dual mechanism appears to provide additive benefits.
Why does research suggest it may work better for some?
The GIP receptor activation provides additional metabolic benefits that some individuals may respond to more favorably. Studies suggest the dual mechanism may help overcome plateaus seen with GLP-1 alone.
What titration schedule did clinical trials use?
Research protocols increased dose every 4 weeks: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg, though many participants achieved goals at lower doses.
Are there cardiovascular benefits like semaglutide?
Cardiovascular outcome trials are ongoing. Early data suggests similar cardioprotective benefits, but dedicated outcomes data is still emerging.
MORE ON TIRZEPATIDE.
§ 10 · FIELD NOTES◆ Education · ★ FEATURE
Beginner's Guide to GLP-1 Peptides: Semaglutide vs Tirzepatide
Everything beginners need to know about GLP-1 peptides — how they work, key differences between semaglutide and tirzepatide, and what researchers report.
11 min·READ →
◆ Comparisons · ★ FEATURE
Semaglutide vs Tirzepatide: Complete Comparison (2026)
In-depth comparison of semaglutide and tirzepatide — mechanisms, weight loss data, side effects, costs, and which GLP-1 peptide is right for different research goals.
14 min·READ →
◆ Education
Are Peptides Safe? What the Research Says
An honest look at peptide safety — FDA-approved vs research peptides, risks, and how to minimize them.
9 min·READ →
◆ THE PEPGAINS DISPATCH
GET THE NEXT UPDATE FIRST.
New research on Tirzepatide + a weekly dispatch on everything else moving in the peptide world. One email. Unsubscribe in a click.